Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real ‐world studies

ConclusionsThe HAT data on hypoglycaemia incidence were comparable with those from other real ‐world studies and indicate a high incidence of hypoglycaemia among insulin‐treated patients. Differences in rates between studies are mostly explained by differences in patient populations and study methodology. The goal of reducing hypoglycaemia should be a target for continued educational and evidence‐based pharmacological interventions.This article is protected by copyright. All rights reserved.

Source: Diabetes, Obesity and Metabolism - November 20, 2018 Category: Endocrinology Authors: Ulrik Pedersen ‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran, Kamlesh Khunti Tags: ORIGINAL ARTICLE Source Type: research